Cargando…
N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
Oxidative stress is a common feature of tuberculosis (TB), and persons with reduced antioxidants are at more risk of TB. TB patients with relatively severe oxidative stress had also more advanced disease as measured by the Karnofsky performance index. Since adverse effects from anti-TB drugs are als...
Autores principales: | Ejigu, Dawit A., Abay, Solomon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210531/ https://www.ncbi.nlm.nih.gov/pubmed/32411461 http://dx.doi.org/10.1155/2020/5907839 |
Ejemplares similares
-
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016) -
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
por: Martinez-Banaclocha, Marcos
Publicado: (2022) -
Impact of N-Acetyl Cysteine (NAC) on Tuberculosis (TB) Patients—A Systematic Review
por: Mapamba, Daniel Adon, et al.
Publicado: (2022) -
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
por: Bradlow, Richard C. J., et al.
Publicado: (2022) -
A Review on Various Uses of N-Acetyl Cysteine
por: Mokhtari, Vida, et al.
Publicado: (2017)